Company news
Rxsight, Inc. (NASDAQ:RXST) news
Every Rxsight, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 2
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
January 7, 2024
RxSight, Inc. Reports Third Quarter 2023 Financial Results
November 9, 2023
RxSight, Inc. Educational and Product Announcements for AAO 2023
November 2, 2023
RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023
October 26, 2023
RxSight, Inc. Reports Second Quarter 2023 Financial Results
August 7, 2023
RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023
July 25, 2023
RxSight, Inc. Reports First Quarter 2023 Financial Results
May 9, 2023
RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023
April 25, 2023
Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting
April 24, 2023
RxSight, Inc. to Present at the Needham Healthcare Conference
April 5, 2023
RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 6, 2023
RxSight, Inc. to Present at the Oppenheimer Healthcare Conference
February 28, 2023
RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
February 21, 2023
RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock
February 14, 2023
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results
January 8, 2023
RxSight, Inc. Reports Third Quarter 2022 Financial Results
November 7, 2022
RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022
October 24, 2022
RxSight, Inc. Reports Second Quarter 2022 Financial Results
August 8, 2022
RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program
August 8, 2022
RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022
July 25, 2022
RxSight, Inc. Reports First Quarter 2022 Financial Results
May 5, 2022
RxSight, Inc. to Report First Quarter 2022 Financial Results on May 5, 2022
April 21, 2022
Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting
April 19, 2022
RxSight, Inc. to Present at the Needham Virtual Healthcare Conference
March 28, 2022
RxSight, Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results
March 8, 2022
RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 8, 2022
February 23, 2022
RxSight, Inc. to Present at the SVB Leerink Global Healthcare Conference
February 3, 2022
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results
January 9, 2022
RxSight, Inc. Appoints Dr. Tamara R. Fountain, M.D. and Shweta Singh Maniar to its Board of Directors
January 4, 2022
RxSight to Present at the J.P. Morgan Healthcare Conference
December 28, 2021
RxSight to Participate in the Ophthalmology Day at BTIG
November 18, 2021
RxSight Reports Third Quarter 2021 Financial Results
November 10, 2021
RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021
October 27, 2021
RxSight Reports Second Quarter 2021 Financial Results
September 9, 2021
RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021
September 1, 2021
RxSight to Participate in the Wells Fargo Healthcare Conference
August 31, 2021
RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021
August 24, 2021
RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales
August 17, 2021
RxSight Announces Appointments to its Board of Directors
August 10, 2021
RxSight, Inc. Announces Closing of Initial Public Offering and Partial Exercise of the Underwriters’ Option to Purchase Additional Shares
August 4, 2021